| Jennifer Crowe Tolo, Md | |
|
1603 116th Ave Ne Ste 110 Bellevue WA 98004-3009 | |
| (425) 458-4895 | |
| (425) 458-4895 |
| Full Name | Jennifer Crowe Tolo, Md |
|---|---|
| Speciality | Family Medicine |
| Location | 1603 116th Ave Ne Ste 110, Bellevue, Washington |
| Authorized Official Name and Position | Jennifer Crowe Tolo (OWNER) |
| Authorized Official Contact | 4258988517 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Crowe Tolo, Md 1722 211th Way Ne Sammamish WA 98074-4218 Ph: (425) 898-8517 | Jennifer Crowe Tolo, Md 1603 116th Ave Ne Ste 110 Bellevue WA 98004-3009 Ph: (425) 458-4895 |
| NPI Number | 1568650448 |
|---|---|
| Provider Enumeration Date | 10/04/2007 |
| Last Update Date | 01/12/2011 |
| Medicare PECOS PAC ID | 8022001890 |
|---|---|
| Medicare Enrollment ID | O20040407000052 |
News Archive
The COVID-19 pandemic has irreversibly altered our lives in many ways. However, available COVID vaccines are effective against (symptomatic) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hospitalizations, and even death. Despite a diminishing protective effect against infection and onward transmission after vaccination, and a slightly diminished effect with the Delta variant compared to the Alpha variant, protection against severe outcomes remains high.
China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced record financial results for its second quarter ended June 30, 2010.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
A new study published in the journal Psychoneuroendocrinology, conducted by the researchers from the Ohio State University Institute for Behavioral Medicine Research indicates that the lack of sleep doesn't just make a person cranky and looking for a fight, it also results in the risk of stress-related inflammation.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568650448 | NPI | - | NPPES |
| 1119221 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD00034260 (Washington) | Primary |
| Provider Name | Jennifer C Tolo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1922023209 PECOS PAC ID: 4284627050 Enrollment ID: I20040415000367 |
News Archive
The COVID-19 pandemic has irreversibly altered our lives in many ways. However, available COVID vaccines are effective against (symptomatic) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hospitalizations, and even death. Despite a diminishing protective effect against infection and onward transmission after vaccination, and a slightly diminished effect with the Delta variant compared to the Alpha variant, protection against severe outcomes remains high.
China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced record financial results for its second quarter ended June 30, 2010.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
A new study published in the journal Psychoneuroendocrinology, conducted by the researchers from the Ohio State University Institute for Behavioral Medicine Research indicates that the lack of sleep doesn't just make a person cranky and looking for a fight, it also results in the risk of stress-related inflammation.
› Verified 5 days ago
News Archive
The COVID-19 pandemic has irreversibly altered our lives in many ways. However, available COVID vaccines are effective against (symptomatic) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, hospitalizations, and even death. Despite a diminishing protective effect against infection and onward transmission after vaccination, and a slightly diminished effect with the Delta variant compared to the Alpha variant, protection against severe outcomes remains high.
China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced record financial results for its second quarter ended June 30, 2010.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.
A new study published in the journal Psychoneuroendocrinology, conducted by the researchers from the Ohio State University Institute for Behavioral Medicine Research indicates that the lack of sleep doesn't just make a person cranky and looking for a fight, it also results in the risk of stress-related inflammation.
› Verified 5 days ago
Mediart Family Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1530 140th Ave Ne Ste 101, Bellevue, WA 98005 Phone: 425-233-8254 Fax: 425-454-7827 | |
Highland Middle School Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15027 Ne Bel Red Rd, Bellevue, WA 98007 Phone: 425-373-3135 | |
Jkw Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 11504 Ne 21st St, Bellevue, WA 98004 Phone: 425-698-3033 Fax: 425-968-6357 | |
Hotel California By The Sea Bellevue, Llc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 114th Ave Se Ste 180, Bellevue, WA 98004 Phone: 844-766-8717 | |
Healthscan Of Washington Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6282 119th Ave Se, Bellevue, WA 98006 Phone: 206-922-9951 | |
Rediclinic Of Wa, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3905 Factoria Mall Se, Bellevue, WA 98006 Phone: 713-335-1754 | |
Kaiser Permanente Bellevue Infusion Pharmacy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3820 Fax: 425-502-3813 |